Literature DB >> 21447981

Non-small cell lung cancer in never-smokers: a new disease entity?

David F Heigener1.   

Abstract

Non-small cell lung cancer (NSCLC) in never-smokers is an increasing entity. It seems that it has a different pathogenesis, at least in some cases, making it more sensitive to targeted therapies. Two promising targets have so far been identified. This article gives an overview on the biologic background and latest developments in the treatment of this particular entity.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh：

Year:  2011        PMID： 21447981     DOI： 10.1159/000326839

Source DB:  PubMed          Journal:  Onkologie        ISSN： 0378-584X


  2 in total

1.  First report of upfront treatment with Gefitinib in comparison with chemotherapy in advanced non-small cell lung cancer patients from south India: Analysis of 120 patients.

Authors:  Robert A Louis; Rejiv Rajendranath; Prasanth Ganesan; T G Sagar; Arvind Krishnamurthy
Journal:  Indian J Med Paediatr Oncol       Date:  2012-07

2.  Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells.

Authors:  Erying Zhang; Xiaowei Feng; Fei Liu; Peihua Zhang; Jie Liang; Xudong Tang
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.